Author:
Barth Stephan W.,Briviba Karlis,Watzl Bernhard,Jäger Nicole,Marko Doris,Esselen Melanie
Subject
Molecular Medicine,Applied Microbiology and Biotechnology,General Medicine
Reference31 articles.
1. Pharmacology of topoisomerase I inhibitors irinotecan (CPT-11) and topotecan.;Mathijssen;Curr. Cancer Drug Targets,2002
2. Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins.;Garcia-Carbonero;Clin. Cancer Res.,2002
3. Clinical pharmacokinetics of irinotecan and its metabolites: A population analysis.;Xie;J. Clin. Oncol.,2002
4. Topoisomerase I inhibitors: Camptothecins and beyond.;Pommier;Nat. Rev. Cancer,2006
5. Metabolic activation of CPT-11, 7-ethyl-10-[4-(1-piperidino)-1piperidino] carbonyloxycamptothecin, a novel antitumor agent, by carboxylesterase.;Satoh;Biol. Pharm. Bull.,1994
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献